A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Clinical trial NCT04551352 · COMPLETED

Trial details

NCT number: NCT04551352
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma Uveal Melanoma Mucosal Melanoma

Start date: 2020-10-28
Primary completion: 2022-07-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.